Nobel Prize Recognizes Pioneering Body's Defenses Research

The prestigious award in Physiology or Medicine has been awarded for revolutionary discoveries that illuminate how the immune system targets dangerous infections while protecting the healthy tissues.

Three esteemed scientists—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their research uncovered specialized "security guards" within the immune system that eliminate rogue defense cells capable of attacking the organism.

The discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer.

These winners will share a prize fund valued at 11 million Swedish kronor.

Decisive Findings

"Their research has been decisive for comprehending how the body's defenses operates and the reason we do not all suffer from severe autoimmune diseases," commented the chair of the Nobel Committee.

The team's research address a fundamental question: In what way does the immune system protect us from numerous infections while leaving our healthy cells unharmed?

Our body's protection system employs white blood cells that scan for signs of disease, even pathogens and germs it has never encountered.

Such cells employ detectors—called receptors—that are generated randomly in countless variations.

That gives the defense network the capacity to fight a wide array of invaders, but the randomness of the process unavoidably creates white blood cells that may target the host.

Security Guards of the Immune System

Researchers earlier understood that some of these problematic white blood cells were destroyed in the thymus—the site where immune cells mature.

This year's award honors the identification of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to neutralize other defenders that attack the healthy cells.

It is known that this process fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel added, "These discoveries have established a novel area of investigation and spurred the development of new therapies, for instance for tumors and immune disorders."

In malignancies, T-regs block the body from attacking the tumor, so research are focused on reducing their quantity.

In self-attack disorders, trials are exploring increasing regulatory T-cells so the body is not being harmed. A similar approach could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Experiments

Prof Shimon Sakaguchi, from a Japanese institution, performed experiments on rodents that had their immune gland extracted, leading to autoimmune disease.

The researcher demonstrated that introducing immune cells from healthy animals could stop the disease—implying there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and people that led to the discovery of a gene critical for how T-regs function.

"Their pioneering work has uncovered how the body's defenses is controlled by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a prominent physiology expert.

"This work is a striking example of how basic physiological study can have broad implications for human health."